Header Logo

Connection

VIVEK SUBBIAH to Erdheim-Chester Disease

Back to Details
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Erdheim-Chester Disease.
VIVEK SUBBIAH
Connection Strength
0.262
Erdheim-Chester Disease
  1. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. JAMA Oncol. 2018 Mar 01; 4(3):384-388.
    View in: PubMed
    Score: 0.154
  2. A tale of two histiocytic disorders. Oncologist. 2013; 18(1):2-4.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.